The future of ICH in toxicology looks promising. As the demand for safer and more effective pharmaceuticals grows, the need for harmonized toxicological assessments will continue to increase. ICH is likely to play an even greater role in integrating innovative methods, such as omics technologies and artificial intelligence, into its guidelines. This will help improve the precision of safety assessments and support the development of new therapeutic agents.
